glp-1 nmda Nature: Dual-active molecules targeting GLP-1R and receptors exhibit superior anti-obesity effects GLP-1 Receptor Agonists | Encyclopedia
Description
This dual action can lead to better blood sugar control and reduced hunger, making it a promising tool for patients who are struggling with weight and diabetes management
Available from: 99
Neurochem Res 44: 13061322
It may involve Medicare negotiating the price for semaglutide with Novo Nordisk, or having insurers pay for it using a subscription model, similar to what was done for hepatitis C treatments when they were first released
Researchers are still learning if weight loss during and after treatment can help reduce the risk of breast cancer recurrence (when the cancer comes back) or other complications
